The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Kinzalmono 20 mg tablets

Bayer AGEU/1/98/091/009-012

Main Information

Trade NameKinzalmono 20 mg tablets
Active SubstancesTelmisartan
Dosage FormTablet
Licence HolderBayer AG
Licence NumberEU/1/98/091/009-012

Group Information

ATC CodeC09CA07 telmisartan


License statusAuthorised
Licence Issued
Legal status*** AWAITING VALUE ***
Supply Status*** AWAITING VALUE ***
Advertising Status*** AWAITING VALUE ***
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0049-003-014
Interchangeable List DocumentPDF of Interchangeable List
« Back